Viewing StudyNCT06267560



Ignite Creation Date: 2024-05-06 @ 8:07 PM
Last Modification Date: 2024-10-26 @ 3:21 PM
Study NCT ID: NCT06267560
Status: RECRUITING
Last Update Posted: 2024-02-20
First Post: 2024-02-12

Brief Title: Lpa Lowering Study of Pelacarsen TQJ230 in US BlackAfrican American and Hispanic Participants With Elevated Lpa and Established ASCVD
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Elevated Lpa and Established Atherosclerotic Cardiovascular Disease
Keywords:
Name View
Pelacarsen TQJ230 View
Elevated Lpa View
Cardiovascular disease View